Trials / Conditions / Inflammatory Myofibroblastic Tumor
Inflammatory Myofibroblastic Tumor
4 registered clinical trials studyying Inflammatory Myofibroblastic Tumor — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors NCT04925609 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |
| Unknown | Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors NCT03874273 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 2 / Phase 3 |
| Terminated | Ceritinib Rare Indications Study in ALK+ Tumors NCT02465528 | Novartis Pharmaceuticals | Phase 2 |
| Active Not Recruiting | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |